RAPT Therapeutics Inc (RAPT)
1.565
-0.14
(-8.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Biomarin Pharmaceutical Inc | 0.1098 |
| Arbutus Biopharma Corp | 0.00 |
| GlycoMimetics Inc | -- |
| FibroGen Inc | -0.3119 |
| Cidara Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 127.18M |
| Total Liabilities (Quarterly) | 17.96M |
| Shareholders Equity (Quarterly) | 109.22M |